Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Head-and-Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04540211
What this trial is testing

Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma

Who this might be right for
Esophageal Cancer
Hoffmann-La Roche 461
Testing effectiveness (Phase 2)Looking for participantsNCT05446467
What this trial is testing

Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Zhejiang Provincial People's Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00720304
What this trial is testing

Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 43
Large-scale testing (Phase 3)Study completedNCT00337532
What this trial is testing

A Phase II Trial Neoadjuvant Paclitaxel and Cisplatin in Patients With Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Bristol-Myers Squibb 50
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT05527782
What this trial is testing

Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Hospital Universitario Doctor Peset 40
Testing effectiveness (Phase 2)UnknownNCT06569459
What this trial is testing

Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital with Nanjing Medical University 60
Early research (Phase 1)Active Not RecruitingNCT04947241
What this trial is testing

Toripalimab Combined With Gemcitabine and Cisplatin Treating Resectable Locally Advanced HNSCC

Who this might be right for
Locally Advanced Head and Neck Squamous Cell CarcinomaNeoadjuvant Therapy
Fifth Affiliated Hospital, Sun Yat-Sen University 20
Early research (Phase 1)Ended earlyNCT03818542
What this trial is testing

Assess the Effects of Multiple Study Drug Regimens in Subjects With Newly Diagnosed Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
AbbVie 3
Large-scale testing (Phase 3)UnknownNCT03708042
What this trial is testing

Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer

Who this might be right for
Stage II Esophageal CancerStage III Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 220
Testing effectiveness (Phase 2)Looking for participantsNCT07353723
What this trial is testing

Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer

Who this might be right for
Head & Neck Cancer
Tang-Du Hospital 10
Large-scale testing (Phase 3)UnknownNCT01598402
What this trial is testing

Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Head and Neck Cancer to Prevent Aspiration Pneumonia

Who this might be right for
Head and Neck Cancer
Radboud University Medical Center 106
Testing effectiveness (Phase 2)Looking for participantsNCT06339619
What this trial is testing

Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 32
Early research (Phase 1)Study completedNCT02051751
What this trial is testing

Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck Cancer

Who this might be right for
Neoplasms, Breast Neoplasms, Head and Neck Neoplasms
Novartis Pharmaceuticals 19
Early research (Phase 1)Ended earlyNCT00080028
What this trial is testing

Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerOropharynx CancerLarynx Cancer+1 more
Pharmacyclics LLC. 18
Not applicableEnded earlyNCT01884129
What this trial is testing

Prognostic Value of CTC in HNSCC Patients

Who this might be right for
RecurrenceMetastasisDeath
Chang Gung Memorial Hospital 53
Testing effectiveness (Phase 2)Study completedNCT02061631
What this trial is testing

Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Sanofi 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07752875
What this trial is testing

LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation

Who this might be right for
Ovarian CancerSmall Cell Lung CancerNon Small Cell Lung Cancer+7 more
LG Chem 250
Testing effectiveness (Phase 2)Study completedNCT00124527
What this trial is testing

Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer

Who this might be right for
Thyroid Cancer
Eisai Inc. 35
Testing effectiveness (Phase 2)Looking for participantsNCT06663059
What this trial is testing

Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study

Who this might be right for
Esophageal Cancer
Tang-Du Hospital 80
Next Page